TM 700Alternative Names: TM-700
Latest Information Update: 12 Jul 2016
At a glance
- Originator TikoMed
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Peripheral arterial occlusive disorders; Stroke
Most Recent Events
- 12 Jul 2016 Phase-I clinical trials in Stroke in Sweden (unspecified route)
- 12 Jul 2016 Phase-I clinical trials in Peripheral arterial occlusive disorders in Sweden (unspecified route)